Literature DB >> 22766343

Assessment of pulmonary endothelial function during invasive testing in children and adolescents with idiopathic pulmonary arterial hypertension.

Christian Apitz1, Rainer Zimmermann, Joachim Kreuder, Christian Jux, Heiner Latus, Joern Pons-Kühnemann, Ines Kock, Peter Bride, Karsten Grosse Kreymborg, Ina Michel-Behnke, Dietmar Schranz.   

Abstract

OBJECTIVES: The purpose of our study was to assess pulmonary endothelial function by vasodilator response to acetylcholine (Ach) administered in segmental pulmonary arteries in children with idiopathic pulmonary arterial hypertension (IPAH). We hypothesized that there was a relationship among pulmonary endothelial response to Ach, severity of the disease, and clinical outcome.
BACKGROUND: IPAH may be associated with pulmonary endothelial dysfunction; however, data regarding the impact of endothelial dysfunction on severity and prognosis of this disease are limited.
METHODS: Forty-three children and adolescents (mean age: 10.4 ± 5.5 years) with IPAH were included in the study. Changes in pulmonary blood flow in response to Ach were determined using intravascular Doppler flow measurements. Pulmonary flow reserve (PFR) was calculated as the ratio of pulmonary blood flow velocity in response to Ach relative to baseline values.
RESULTS: Mean PFR of all patients was 1.58 ± 0.67. Mean follow-up after catheterization was 55.7 ± 41.9 months. Freedom from serious cardiovascular events (lung transplantation or death) was 83% after 2 years, 76% after 3 years, and 57% after 5 years. PFR was related significantly to World Health Organization functional class. Receiver-operating characteristic curves revealed a PFR of 1.4 as the best cutoff value. Kaplan-Meier analysis demonstrated that a PFR of <1.4 was highly predictive for cardiovascular events (log-rank [Mantel Cox] chi-square: 12.49, p < 0.0001).
CONCLUSIONS: Our study demonstrates a strong relationship between pulmonary endothelial response to Ach and prognosis of children with IPAH. As an adjunct to the usual testing protocol, this method provides additional information for therapeutic guidance.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766343     DOI: 10.1016/j.jacc.2012.04.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

Review 1.  Treatment of pulmonary arterial hypertension in children.

Authors:  Heiner Latus; Tammo Delhaas; Dietmar Schranz; Christian Apitz
Journal:  Nat Rev Cardiol       Date:  2015-02-03       Impact factor: 32.419

2.  Targeting Pulmonary Endothelial Hemoglobin α Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction.

Authors:  Roger A Alvarez; Megan P Miller; Scott A Hahn; Joseph C Galley; Eileen Bauer; Timothy Bachman; Jian Hu; John Sembrat; Dmitry Goncharov; Ana L Mora; Mauricio Rojas; Elena Goncharova; Adam C Straub
Journal:  Am J Respir Cell Mol Biol       Date:  2017-12       Impact factor: 6.914

3.  Systemic arterial endothelial function in children and young adults with idiopathic pulmonary arterial hypertension: is there a relation to pulmonary endothelium-dependent relaxation?

Authors:  Heiner Latus; Anna Werz; Ines Kock; Stefan Rupp; Gunter Kerst; Joachim Kreuder; Dietmar Schranz; Christian Apitz
Journal:  Pediatr Cardiol       Date:  2014-01-19       Impact factor: 1.655

4.  Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.

Authors:  Heiner Latus; Inken Wagner; Stefan Ostermayer; Gunter Kerst; Joachim Kreuder; Dietmar Schranz; Christian Apitz
Journal:  Pediatr Cardiol       Date:  2017-07-05       Impact factor: 1.655

5.  Hemodynamic and prognostic impact of the diastolic pulmonary arterial pressure in children with pulmonary arterial hypertension-a registry-based analysis.

Authors:  Christian Apitz; Rolf M F Berger; D Dunbar Ivy; Tilman Humpl; Damien Bonnet; Maurice Beghetti; Dietmar Schranz; Heiner Latus
Journal:  Cardiovasc Diagn Ther       Date:  2021-08

6.  Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces.

Authors:  Maria Jesus Del Cerro; Shahin Moledina; Sheila G Haworth; Dunbar Ivy; Maha Al Dabbagh; Hanaa Banjar; Gabriel Diaz; Alexandria Heath-Freudenthal; Ahmed Nasser Galal; Tilman Humpl; Snehal Kulkarni; Antonio Lopes; Ana Olga Mocumbi; G D Puri; Beyra Rossouw; S Harikrishnan; Anita Saxena; Patience Udo; Lina Caicedo; Omar Tamimi; Ian Adatia
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

7.  Noninvasive detection of impaired pulmonary artery endothelial function in people living with HIV.

Authors:  Erin Goerlich; Monica Mukherjee; Michael Schar; Todd T Brown; Gabriele Bonanno; Robert G Weiss; Allison G Hays
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.632

8.  Creation of a restrictive atrial communication in pulmonary arterial hypertension (PAH): effective palliation of syncope and end-stage heart failure.

Authors:  Anna Bauer; Markus Khalil; Dorle Schmidt; Jürgen Bauer; Anoosh Esmaeili; Christian Apitz; Norbert F Voelkel; Dietmar Schranz
Journal:  Pulm Circ       Date:  2018-04-25       Impact factor: 3.017

Review 9.  A Clinical Approach to Multimodality Imaging in Pulmonary Hypertension.

Authors:  Christine Farrell; Aparna Balasubramanian; Allison G Hays; Steven Hsu; Steven Rowe; Stefan L Zimmerman; Paul M Hassoun; Stephen C Mathai; Monica Mukherjee
Journal:  Front Cardiovasc Med       Date:  2022-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.